Solange Peters, MD, PhD, Centre Hospitalier Universitaire Vaudois
Advertisement
Articles by Solange Peters, MD, PhD, Centre Hospitalier Universitaire Vaudois
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Durvalumab Plus Enfortumab Vedotin Improves Survival in Cisplatin-Ineligible MIBC
2
Adjuvant Intismeran Autogene Plus Pembrolizumab Improves RFS and DMFS in Melanoma
3
Perioperative Enfortumab Vedotin Plus Pembrolizumab Improves ctDNA Clearance in Cisplatin-Eligible MIBC
4
Atirmociclib Plus Fulvestrant Improves PFS in HR+/HER2– Advanced Breast Cancer
5